Shares of U.K. pharmaceutical giant GSK rallied on Monday after it turned to an insider to become its next CEO.
The Fed pivoting back to a hawkish stance is the biggest risk facing the market right now, HSBC said.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback